Company / Operating Income per Share
Arcus Biosciences, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$4.19
FY2025
5-year range
-$4.66 / $0.83
FY2021-FY2025
Trend
+4.2%
vs FY2024
Sector context
#164 of 201
Health Care
What the data says
Arcus Biosciences, Inc.'s operating income per share of $-4.19 is lower than 82% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-29.23 in FY2017 to $0.83 in FY2021.
Based on SEC 10-K filings.
-4.19 in FY2025.
Improved from $-4.66 to $-4.19 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 201This company -$4.19 Sector average -$28.56
▼
+85.3% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 4.2% year-over-year.
- Ranks #164 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.19 | +4.2% |
| FY2024 | -$4.37 | +6.3% |
| FY2023 | -$4.66 | -166.3% |
| FY2022 | -$1.75 | -311.2% |
| FY2021 | $0.83 | +169.4% |
| FY2020 | -$1.19 | +40.0% |
| FY2019 | -$1.99 | +55.2% |
| FY2018 | -$4.44 | +84.8% |
| FY2017 | -$29.23 | -38.9% |
| FY2016 | -$21.04 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026